Page last updated: 2024-11-02

phenylbutazone and Adrenal Cancer

phenylbutazone has been researched along with Adrenal Cancer in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meakawa, A1
Onodera, H1
Tanigawa, H1
Furuta, K1
Kanno, J1
Matsuoka, C1
Ogiu, T1
Hayashi, Y1

Other Studies

1 other study available for phenylbutazone and Adrenal Cancer

ArticleYear
Long-term studies on carcinogenicity and promoting effect of phenylbutazone in DONRYU rats.
    Journal of the National Cancer Institute, 1987, Volume: 79, Issue:3

    Topics: Adrenal Gland Neoplasms; Animals; Drug Synergism; Ethylnitrosourea; Female; Leukemia, Experimental;

1987